LOC100130899: A Potential Drug Target and Biomarker (G100130899)

LOC100130899: A Potential Drug Target and Biomarker

LOC100130899 is a gene that has not been characterized previously. It is located on chromosome 6p21.3 and encodes a protein known as LOC100130899. LOC100130899 is a protein that is expressed in various tissues and cells of the human body, including the brain, heart, liver, and muscle. It is also known as SCL/TAL1, which is a transcription factor that plays a role in cell proliferation, differentiation, and survival.

Potential Drug Target

LOC100130899 is a potential drug target because it is a transcription factor that is involved in the regulation of gene expression. This means that if a drug can modulate the activity of LOC100130899, it may be able to interfere with the function of the gene and lead to therapeutic effects. Additionally, LOC100130899 is known to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This suggests that targeting LOC100130899 may be a promising strategy for the development of new treatments for these diseases.

Biomarker

LOC100130899 may also be a biomarker for certain diseases. For example, high levels of LOC100130899 have been observed in the brains of individuals with Alzheimer's disease. Additionally, LOC100130899 has been shown to be expressed in various types of cancer, including breast, lung, and ovarian cancer. This suggests that LOC100130899 may be a useful biomarker for certain types of cancer.

Expression Analysis

To further investigate the function of LOC100130899, researchers have used RNA sequencing (RNA-seq) to analyze its expression in various tissues and cells of the human body. RNA-seq is a powerful tool that allows researchers to identify the expressed genes in a given sample. By analyzing the expression levels of LOC100130899 in different tissues and cells, researchers have been able to determine its functions in cell proliferation, differentiation, and survival.

Functional Analysis

One of the key functions of LOC100130899 is its role in the regulation of cell proliferation. Studies have shown that LOC100130899 is involved in the G1/S transition, which is a critical step in the cell cycle that allows cells to prepare for cell division. Additionally, LOC100130899 has been shown to play a role in the regulation of cell differentiation, as it has been shown to be involved in the development of various tissues and organs in the body.

Another function of LOC100130899 is its role in the regulation of cell survival. Studies have shown that LOC100130899 is involved in the regulation of apoptosis, which is a natural process that helps cells to eliminate themselves when they are no longer needed. Additionally, LOC100130899 has been shown to play a role in the regulation of autophagy, which is the process by which cells break down and recycle their own damaged or unnecessary components.

Drug Targeting

LOC100130899 is a potential drug target because it is involved in the regulation of cell proliferation, differentiation, and survival. This means that if a drug can modulate the activity of LOC100130899, it may be able to interfere with the function of the gene and lead to therapeutic effects. Additionally, LOC100130899 is known to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This suggests that targeting LOC100130899 may be

Protein Name: Uncharacterized LOC100130899

The "LOC100130899 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100130899 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC100130938 | LOC100130987 | LOC100130992 | LOC100131096 | LOC100131107 | LOC100131257 | LOC100131289 | LOC100131372 | LOC100131496 | LOC100131532 | LOC100131626 | LOC100131635 | LOC100131859 | LOC100131877 | LOC100131943 | LOC100132004 | LOC100132062 | LOC100132077 | LOC100132078 | LOC100132249 | LOC100132287 | LOC100132356 | LOC100132609 | LOC100132626 | LOC100132651 | LOC100132686 | LOC100132741 | LOC100132781 | LOC100132797 | LOC100133077 | LOC100133165 | LOC100133177 | LOC100133284 | LOC100133331 | LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735 | LOC100271840 | LOC100272216 | LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076 | LOC100506124 | LOC100506207 | LOC100506236 | LOC100506274 | LOC100506281 | LOC100506379 | LOC100506403 | LOC100506422